Autism spectrum disorder (ASD) is a complex neurodevelopmental condition with lifelong impacts. Genetic and environmental factors contribute to ASD etiology, which remains incompletely understood. Research on ASD epidemiology has made significant advances in the past decade. Current prevalence is estimated to be at least 1.5% in developed countries, with recent increases primarily among those without comorbid intellectual disability. Genetic studies have identified a number of rare de novo mutations and gained footing in the areas of polygenic risk, epigenetics, and gene-by-environment interaction. Epidemiologic investigations focused on nongenetic factors have established advanced parental age and preterm birth as ASD risk factors, indicated that prenatal exposure to air pollution and short interpregnancy interval are potential risk factors, and suggested the need for further exploration of certain prenatal nutrients, metabolic conditions, and exposure to endocrine-disrupting chemicals. We discuss future challenges and goals for ASD epidemiology as well as public health implications.


Article metrics loading...

Loading full text...

Full text loading...


Literature Cited

  1. Abdallah MW, Larsen N, Mortensen EL, Atladottir HO, Norgaard-Pedersen B. 1.  et al. 2012. Neonatal levels of cytokines and risk of autism spectrum disorders: an exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J. Neuroimmunol. 252:75–82 [Google Scholar]
  2. Abel KM, Dalman C, Svensson AC, Susser E, Dal H. 2.  et al. 2013. Deviance in fetal growth and risk of autism spectrum disorder. Am. J. Psychiatry 170:391–98 [Google Scholar]
  3. 3. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ., 5th ed.. [Google Scholar]
  4. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 4.  1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185–88 [Google Scholar]
  5. Argos M. 5.  2015. Arsenic exposure and epigenetic alterations: recent findings based on the Illumina 450K DNA Methylation Array. Curr. Environ. Health Rep. 2:137–44 [Google Scholar]
  6. Atladottir HO, Gyllenberg D, Langridge A, Sandin S, Hansen SN. 6.  et al. 2015. The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison. Eur. Child Adolesc. Psychiatry 24:173–83 [Google Scholar]
  7. Atladóttir HO, Pedersen MG, Thorsen P, Mortensen PB, Deleuran B. 7.  et al. 2009. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 124:687–94 [Google Scholar]
  8. 8. Autism Dev. Disabil. Monit. Netw., Cent. Dis. Control Prev. 2007. Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002. MMWR Surveill. Summ 56:12–28 [Google Scholar]
  9. 9. Autism Dev. Disabil. Monit. Netw., Cent. Dis. Control Prev. 2012. Prevalence of autism spectrum disorders–Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill. Summ 61:1–19 [Google Scholar]
  10. Bauman ML, Kemper TL. 10.  2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci. 23:183–87 [Google Scholar]
  11. Baxter AJ, Brugha TS, Erskine HE, Scheurer RW, Vos T, Scott JG. 11.  2015. The epidemiology and global burden of autism spectrum disorders. Psychol. Med. 45:601–13 [Google Scholar]
  12. Bay B, Mortensen EL, Hvidtjorn D, Kesmodel US. 12.  2013. Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study. BMJ 347:f3978 [Google Scholar]
  13. Becerra TA, Wilhelm M, Olsen J, Cockburn M, Ritz B. 13.  2013. Ambient air pollution and autism in Los Angeles County, California. Environ. Health Perspect. 121:380–86 [Google Scholar]
  14. Bercum FM, Rodgers KM, Benison AM, Smith ZZ, Taylor J. 14.  et al. 2015. Maternal stress combined with terbutaline leads to comorbid autistic-like behavior and epilepsy in a rat model. J. Neurosci. 35:15894–902 [Google Scholar]
  15. Black MM. 15.  2008. Effects of vitamin B12 and folate deficiency on brain development in children. Food Nutr. Bull. 29:S126–31 [Google Scholar]
  16. Bolton PF, Murphy M, Macdonald H, Whitlock B, Pickles A, Rutter M. 16.  1997. Obstetric complications in autism: consequences or causes of the condition?. J. Am. Acad. Child Adolesc. Psychiatry 36:272–81 [Google Scholar]
  17. Borue X, Chen J, Condron BG. 17.  2007. Developmental effects of SSRIs: lessons learned from animal studies. Int. J. Dev. Neurosci. 25:341–47 [Google Scholar]
  18. Bourgeron T. 18.  2015. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat. Rev. Neurosci. 16:551–63 [Google Scholar]
  19. Braun JM, Froehlich T, Kalkbrenner A, Pfeiffer CM, Fazili Z. 19.  et al. 2014. Brief report: Are autistic-behaviors in children related to prenatal vitamin use and maternal whole blood folate concentrations?. J. Autism Dev. Disord. 44:2602–7 [Google Scholar]
  20. Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM. 20.  et al. 2014. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study. Environ. Health Perspect. 122:5513–20 [Google Scholar]
  21. Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J. 21.  et al. 2013. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J. Neurol. Neurosurg. Psychiatry 84:637–43 [Google Scholar]
  22. Brown AS, Sourander A, Hinkka-Yli-Salomaki S, McKeague IW, Sundvall J, Surcel HM. 22.  2014. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol. Psychiatry 19:259–64 [Google Scholar]
  23. Brugha TS, McManus S, Bankart J, Scott F, Purdon S. 23.  et al. 2011. Epidemiology of autism spectrum disorders in adults in the community in England. Arch. Gen. Psychiatry 68:459–65 [Google Scholar]
  24. Bryson SE, Smith IM, Eastwood D. 24.  1988. Obstetrical suboptimality in autistic children. J. Am. Acad. Child Adolesc. Psychiatry 27:418–22 [Google Scholar]
  25. Buescher AV, Cidav Z, Knapp M, Mandell DS. 25.  2014. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 168:721–28 [Google Scholar]
  26. Buie T, Campbell DB, Fuchs GJ III, Furuta GT, Levy J. 26.  et al. 2010. Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125:Suppl. 1S1–18 [Google Scholar]
  27. Buiting K, Saitoh S, Gross S, Dittrich B, Schwartz S. 27.  et al. 1995. Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15. Nat. Genet. 9:395–400 [Google Scholar]
  28. Chaidez V, Hansen RL, Hertz-Picciotto I. 28.  2013. Gastrointestinal problems in children with autism, developmental delays or typical development. J. Autism Dev. Disord. 44:51117–27 [Google Scholar]
  29. Chen JA, Penagarikano O, Belgard TG, Swarup V, Geschwind DH. 29.  2015. The emerging picture of autism spectrum disorder: genetics and pathology. Annu. Rev. Pathol. 10:111–44 [Google Scholar]
  30. Cheslack-Postava K, Liu K, Bearman PS. 30.  2011. Closely spaced pregnancies are associated with increased odds of autism in California sibling births. Pediatrics 127:246–53 [Google Scholar]
  31. Cheslack-Postava K, Rantakokko PV, Hinkka-Yli-Salomaki S, Surcel HM, McKeague IW. 31.  et al. 2013. Maternal serum persistent organic pollutants in the Finnish Prenatal Study of Autism: a pilot study. Neurotoxicol. Teratol. 38:1–5 [Google Scholar]
  32. Cheslack-Postava K, Suominen A, Jokiranta E, Lehti V, McKeague IW. 32.  et al. 2014. Increased risk of autism spectrum disorders at short and long interpregnancy intervals in Finland. J. Am. Acad. Child Adolesc. Psychiatry 53:1074–81.e4 [Google Scholar]
  33. Choi GB, Yim YS, Wong H, Kim S, Kim H. 33.  et al. 2016. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351:933–39 [Google Scholar]
  34. Christensen DL, Baio J, Braun KV, Bilder D, Charles J. 34.  et al. 2016. Prevalence and characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2012. MMWR Surveill. Summ. 65:1–23 [Google Scholar]
  35. Christensen J, Gronborg TK, Sorensen MJ, Schendel D, Parner ET. 35.  et al. 2013. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696–703 [Google Scholar]
  36. Colvert E, Tick B, McEwen F, Stewart C, Curran SR. 36.  et al. 2015. Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry 72:415–23 [Google Scholar]
  37. Coo H, Ouellette-Kuntz H, Lam YM, Brownell M, Flavin MP, Roos LL. 37.  2015. The association between the interpregnancy interval and autism spectrum disorder in a Canadian cohort. Can. J. Public Health/Rev. Can. Santé Publique 106:e36–42 [Google Scholar]
  38. Crider KS, Bailey LB, Berry RJ. 38.  2011. Folic acid food fortification—its history, effect, concerns, and future directions. Nutrients 3:370–84 [Google Scholar]
  39. Croen LA, Connors SL, Matevia M, Qian Y, Newschaffer C, Zimmerman AW. 39.  2011. Prenatal exposure to β2-adrenergic receptor agonists and risk of autism spectrum disorders. J. Neurodev. Disord. 3:4307–15 [Google Scholar]
  40. Croen LA, Grether JK, Yoshida CK, Odouli R, Van de Water J. 40.  2005. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch. Pediatr. Adolesc. Med. 159:151–57 [Google Scholar]
  41. Croen LA, Zerbo O, Qian Y, Massolo ML, Rich S. 41.  et al. 2015. The health status of adults on the autism spectrum. Autism 19:814–23 [Google Scholar]
  42. Lee SH, Ripke S, Neale BM, Faraone SV. 42. Cross-Disord. Group Psychiatr. Genom. Consort. et al. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45:984–94 [Google Scholar]
  43. Curran EA, Cryan JF, Kenny LC, Dinan TG, Kearney PM, Khashan AS. 43.  2016. Obstetrical mode of delivery and childhood behavior and psychological development in a British cohort. J. Autism Dev. Disord. 46:603–14 [Google Scholar]
  44. Curran EA, Dalman C, Kearney PM, Kenny LC, Cryan JF. 44.  et al. 2015. Association between obstetric mode of delivery and autism spectrum disorder: a population-based sibling design study. JAMA Psychiatry 72:935–42 [Google Scholar]
  45. Curran EA, O'Neill SM, Cryan JF, Kenny LC, Dinan TG. 45.  et al. 2015. Research review: birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. J. Child Psychol. Psychiatry 56:500–8 [Google Scholar]
  46. Cuthbert BN, Insel TR. 46.  2013. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 11:126 [Google Scholar]
  47. de la Torre-Ubieta L, Won H, Stein JL, Geschwind DH. 47.  2016. Advancing the understanding of autism disease mechanisms through genetics. Nat. Med. 22:345–61 [Google Scholar]
  48. DeVilbiss EA, Gardner RM, Newschaffer CJ, Lee BK. 48.  2015. Maternal folate status as a risk factor for autism spectrum disorders: a review of existing evidence. Br. J. Nutr. 114:663–72 [Google Scholar]
  49. Devlin B, Scherer SW. 49.  2012. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev. 22:229–37 [Google Scholar]
  50. Di Martino A, Yan CG, Li Q, Denio E, Castellanos FX. 50.  et al. 2014. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol. Psychiatry 19:659–67 [Google Scholar]
  51. Dodds L, Fell DB, Shea S, Armson BA, Allen AC, Bryson S. 51.  2011. The role of prenatal, obstetric and neonatal factors in the development of autism. J. Autism Dev. Disord. 41:891–902 [Google Scholar]
  52. Durkin MS, DuBois LA, Maenner MJ. 52.  2015. Inter-pregnancy intervals and the risk of autism spectrum disorder: results of a population-based study. J. Autism Dev. Disord. 45:2056–66 [Google Scholar]
  53. Durkin MS, Maenner MJ, Meaney FJ, Levy SE, DiGuiseppi C. 53.  et al. 2010. Socioeconomic inequality in the prevalence of autism spectrum disorder: evidence from a U.S. cross-sectional study. PLOS ONE 5:e11551 [Google Scholar]
  54. Dworzynski K, Ronald A, Bolton P, Happe F. 54.  2012. How different are girls and boys above and below the diagnostic threshold for autism spectrum disorders?. J. Am. Acad. Child Adolesc. Psychiatry 51:788–97 [Google Scholar]
  55. Eliasen M, Tolstrup JS, Nybo Andersen AM, Gronbaek M, Olsen J, Strandberg-Larsen K. 55.  2010. Prenatal alcohol exposure and autistic spectrum disorders—a population-based prospective study of 80,552 children and their mothers. Int. J. Epidemiol. 39:1074–81 [Google Scholar]
  56. Elison JT, Paterson SJ, Wolff JJ, Reznick JS, Sasson NJ. 56.  et al. 2013. White matter microstructure and atypical visual orienting in 7-month-olds at risk for autism. Am. J. Psychiatry 170:899–908 [Google Scholar]
  57. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S. 57.  et al. 2012. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 5:160–79 [Google Scholar]
  58. Erskine HE, Baxter AJ, Patton G, Moffitt TE, Patel V. 58.  et al. 2016. The global coverage of prevalence data for mental disorders in children and adolescents. Epidemiol. Psychiatr. Sci. In press https://doi.org/10.1017/S2045796015001158 [Google Scholar]
  59. Eskenazi B, Marks AR, Bradman A, Harley K, Barr DB. 59.  et al. 2007. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect. 115:792–98 [Google Scholar]
  60. Fountain C, Zhang Y, Kissin DM, Schieve LA, Jamieson DJ. 60.  et al. 2015. Association between assisted reproductive technology conception and autism in California, 1997–2007. Am. J. Public Health 105:963–71 [Google Scholar]
  61. Fox-Edmiston E, Van de Water J. 61.  2015. Maternal anti-fetal brain IgG autoantibodies and autism spectrum disorder: current knowledge and its implications for potential therapeutics. CNS Drugs 29:715–24 [Google Scholar]
  62. Gardener H, Spiegelman D, Buka SL. 62.  2009. Prenatal risk factors for autism: comprehensive meta-analysis. Br. J. Psychiatry 195:7–14 [Google Scholar]
  63. Gardener H, Spiegelman D, Buka SL. 63.  2011. Perinatal and neonatal risk factors for autism: a comprehensive meta-analysis. Pediatrics 128:344–55 [Google Scholar]
  64. Gauderman WJ, Zhang P, Morrison JL, Lewinger JP. 64.  2013. Finding novel genes by testing G × E interactions in a genome-wide association study. Genet. Epidemiol. 37:603–13 [Google Scholar]
  65. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP. 65.  et al. 2014. Most genetic risk for autism resides with common variation. Nat. Genet. 46:881–85 [Google Scholar]
  66. Gentile S. 66.  2015. Prenatal antidepressant exposure and the risk of autism spectrum disorders in children: Are we looking at the fall of Gods?. J. Affect. Disord. 182:132–37 [Google Scholar]
  67. Gidaya NB, Lee BK, Burstyn I, Michael Y, Newschaffer CJ, Mortensen EL. 67.  2016. In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders. Pediatrics 137:1–8 [Google Scholar]
  68. Goines PE, Croen LA, Braunschweig D, Yoshida CK, Grether J. 68.  et al. 2011. Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: a case-control study. Mol. Autism 2:13 [Google Scholar]
  69. Gong T, Almqvist C, Bolte S, Lichtenstein P, Anckarsater H. 69.  et al. 2014. Exposure to air pollution from traffic and neurodevelopmental disorders in Swedish twins. Twin Res. Hum. Genet. 17:553–62 [Google Scholar]
  70. Grandjean P, Landrigan PJ. 70.  2014. Neurobehavioural effects of developmental toxicity. Lancet Neurol 13:330–38 [Google Scholar]
  71. Gronborg TK, Schendel DE, Parner ET. 71.  2013. Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: a population-based cohort study. JAMA Pediatr 167:10947–53 [Google Scholar]
  72. Guinchat V, Thorsen P, Laurent C, Cans C, Bodeau N, Cohen D. 72.  2012. Pre-, peri- and neonatal risk factors for autism. Acta Obstet. Gynecol. Scand. 91:287–300 [Google Scholar]
  73. Gunnes N, Suren P, Bresnahan M, Hornig M, Lie KK. 73.  et al. 2013. Interpregnancy interval and risk of autistic disorder. Epidemiology 24:906–12 [Google Scholar]
  74. Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS. 74.  et al. 2014. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat. Commun. 5:5748 [Google Scholar]
  75. Guxens M, Ghassabian A, Gong T, Garcia-Esteban R, Porta D. 75.  et al. 2016. Air pollution exposure during pregnancy and childhood autistic traits in four European population-based cohort studies: the ESCAPE project. Environ. Health Perspect. 124:1133–40 [Google Scholar]
  76. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B. 76.  et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68:1095–102 [Google Scholar]
  77. Hansen SN, Schendel DE, Parner ET. 77.  2015. Explaining the increase in the prevalence of autism spectrum disorders: the proportion attributable to changes in reporting practices. JAMA Pediatr 169:56–62 [Google Scholar]
  78. Hertz-Picciotto I, Delwiche L. 78.  2009. The rise in autism and the role of age at diagnosis. Epidemiology 20:84–90 [Google Scholar]
  79. Hertz-Picciotto I, Park HY, Dostal M, Kocan A, Trnovec T, Sram R. 79.  2008. Prenatal exposures to persistent and non-persistent organic compounds and effects on immune system development. Basic Clin. Pharmacol. Toxicol. 102:146–54 [Google Scholar]
  80. Hirvikoski T, Mittendorfer-Rutz E, Boman M, Larsson H, Lichtenstein P, Bolte S. 80.  2016. Premature mortality in autism spectrum disorder. Br. J. Psychiatry 208:232–38 [Google Scholar]
  81. Hurley AM, Tadrous M, Miller ES. 81.  2010. Thimerosal-containing vaccines and autism: a review of recent epidemiologic studies. J. Pediatr. Pharmacol. Ther. 15:173–81 [Google Scholar]
  82. Hus V, Gotham K, Lord C. 82.  2014. Standardizing ADOS domain scores: separating severity of social affect and restricted and repetitive behaviors. J. Autism Dev. Disord. 44:2400–12 [Google Scholar]
  83. Hvidtjorn D, Grove J, Schendel D, Schieve LA, Svaerke C. 83.  et al. 2011. Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study. J. Epidemiol. Community Health 65:497–502 [Google Scholar]
  84. Idring S, Lundberg M, Sturm H, Dalman C, Gumpert C. 84.  et al. 2015. Changes in prevalence of autism spectrum disorders in 2001–2011: findings from the Stockholm youth cohort. J. Autism Dev. Disord. 45:1766–73 [Google Scholar]
  85. Idring S, Magnusson C, Lundberg M, Ek M, Rai D. 85.  et al. 2014. Parental age and the risk of autism spectrum disorders: findings from a Swedish population-based cohort. Int. J. Epidemiol. 43:107–15 [Google Scholar]
  86. 86. Inst. Med. 2004. Immunization Safety Review: Vaccines and Autism. Washington, DC: Natl. Acad. Press [Google Scholar]
  87. 87. Inst. Med. 2011. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: Natl. Acad. Press [Google Scholar]
  88. 88. Inst. Med. 2013. The Childhood Immunization Schedule and Safety. Washington, DC: Natl. Acad. Press [Google Scholar]
  89. Jain A, Spencer D, Yang W, Kelly JP, Newschaffer CJ. 89.  et al. 2014. Injuries among children with autism spectrum disorder. Acad. Pediatr. 14:390–97 [Google Scholar]
  90. Johnson RA, Danis M, Hafner-Eaton C. 90.  2014. US state variation in autism insurance mandates: balancing access and fairness. Autism 18:803–14 [Google Scholar]
  91. Joubert BR, Felix JF, Yousefi P, Bakulski KM, Just AC. 91.  et al. 2016. DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis. Am. J. Hum. Genet. 98:680–96 [Google Scholar]
  92. Jung CR, Lin YT, Hwang BF. 92.  2013. Air pollution and newly diagnostic autism spectrum disorders: a population-based cohort study in Taiwan. PLOS ONE 8:e75510 [Google Scholar]
  93. Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard AR. 93.  et al. 2016. Inflammation in complicated pregnancy and its outcome. Am. J. Perinatol. In press. https://doi.org/10.1055/s-0036-1582397 [Google Scholar]
  94. Kalkbrenner AE, Daniels JL, Chen JC, Poole C, Emch M, Morrissey J. 94.  2010. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology 21:631–41 [Google Scholar]
  95. Kalkbrenner AE, Schmidt RJ, Penlesky AC. 95.  2014. Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence. Curr. Probl. Pediatr. Adolesc. Health Care 44:277–318 [Google Scholar]
  96. Kalkbrenner AE, Windham GC, Serre ML, Akita Y, Wang X. 96.  et al. 2015. Particulate matter exposure, prenatal and postnatal windows of susceptibility, and autism spectrum disorders. Epidemiology 26:30–42 [Google Scholar]
  97. Kapp SK, Gillespie-Lynch K, Sherman LE, Hutman T. 97.  2013. Deficit, difference, or both? Autism and neurodiversity. Dev. Psychol. 49:59–71 [Google Scholar]
  98. Keil A, Daniels JL, Forssen U, Hultman C, Cnattingius S. 98.  et al. 2010. Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology 21:805–8 [Google Scholar]
  99. Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E. 99.  et al. 2011. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry 168:904–12 [Google Scholar]
  100. King BH. 100.  2016. Psychiatric comorbidities in neurodevelopmental disorders. Curr. Opin. Neurol. 29:113–17 [Google Scholar]
  101. King MD, Bearman PS. 101.  2011. Socioeconomic status and the increased prevalence of autism in California. Am. Sociol. Rev. 76:320–46 [Google Scholar]
  102. Kohane IS, McMurry A, Weber G, MacFadden D, Rappaport L. 102.  et al. 2012. The co-morbidity burden of children and young adults with autism spectrum disorders. PLOS ONE 7:e33224 [Google Scholar]
  103. Kolevzon A, Gross R, Reichenberg A. 103.  2007. Prenatal and perinatal risk factors for autism: a review and integration of findings. Arch. Pediatr. Adolesc. Med. 161:326–33 [Google Scholar]
  104. Kortenkamp A. 104.  2011. Are cadmium and other heavy metal compounds acting as endocrine disrupters?. Metal Ions Life Sci 8:305–17 [Google Scholar]
  105. Krakowiak P, Goines PE, Tancredi DJ, Ashwood P, Hansen RL. 105.  et al. 2015. Neonatal cytokine profiles associated with autism spectrum disorder. Biol. Psychiatry. In press. https://doi.org/10.1016/j.biopsych.2015.08.007 [Google Scholar]
  106. Krakowiak P, Walker CK, Bremer AA, Baker AS, Ozonoff S. 106.  et al. 2012. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129:e1121–28 [Google Scholar]
  107. Kuzniewicz MW, Wi S, Qian Y, Walsh EM, Armstrong MA, Croen LA. 107.  2014. Prevalence and neonatal factors associated with autism spectrum disorders in preterm infants. J. Pediatr. 164:20–25 [Google Scholar]
  108. Ladd-Acosta C, Fallin MD. 108.  2016. The role of epigenetics in genetic and environmental epidemiology. Epigenomics 8:271–83 [Google Scholar]
  109. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. 109.  2014. Common DNA methylation alterations in multiple brain regions in autism. Mol. Psychiatry 19:862–71 [Google Scholar]
  110. Ladd-Acosta C, Shu C, Lee BK, Gidaya N, Singer A. 110.  et al. 2016. Presence of an epigenetic signature of prenatal cigarette smoke exposure in childhood. Environ. Res. 144:139–48 [Google Scholar]
  111. Lampi KM, Lehtonen L, Tran PL, Suominen A, Lehti V. 111.  et al. 2012. Risk of autism spectrum disorders in low birth weight and small for gestational age infants. J. Pediatr. 161:830–36 [Google Scholar]
  112. Larsson M, Weiss B, Janson S, Sundell J, Bornehag CG. 112.  2009. Associations between indoor environmental factors and parental-reported autistic spectrum disorders in children 6–8 years of age. Neurotoxicology 30:822–31 [Google Scholar]
  113. Leavey A, Zwaigenbaum L, Heavner K, Burstyn I. 113.  2013. Gestational age at birth and risk of autism spectrum disorders in Alberta, Canada. J. Pediatr. 162:361–68 [Google Scholar]
  114. Lee BK, Magnusson C, Gardner RM, Blomstrom A, Newschaffer CJ. 114.  et al. 2015. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav. Immun. 44:100–5 [Google Scholar]
  115. Lee BK, McGrath JJ. 115.  2015. Advancing parental age and autism: multifactorial pathways. Trends Mol. Med. 21:118–25 [Google Scholar]
  116. Lefebvre A, Beggiato A, Bourgeron T, Toro R. 116.  2015. Neuroanatomical diversity of corpus callosum and brain volume in autism: meta-analysis, analysis of the autism brain imaging data exchange project, and simulation. Biol. Psychiatry 78:126–34 [Google Scholar]
  117. Leigh JP, Du J. 117.  2015. Brief report: forecasting the economic burden of autism in 2015 and 2025 in the United States. J. Autism Dev. Disord. 45:4135–39 [Google Scholar]
  118. Li M, Fallin MD, Riley A, Landa R, Walker SO. 118.  et al. 2016. The association of maternal obesity and diabetes with autism and other developmental disabilities. Pediatrics 137:1–10 [Google Scholar]
  119. Li YM, Ou JJ, Liu L, Zhang D, Zhao JP, Tang SY. 119.  2016. Association between maternal obesity and autism spectrum disorder in offspring: a meta-analysis. J. Autism Dev. Disord. 46:95–102 [Google Scholar]
  120. Liew Z, Ritz B, von Ehrenstein OS, Bech BH, Nohr EA. 120.  et al. 2015. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort. Environ. Health Perspect. 123:367–73 [Google Scholar]
  121. Liu KY, King M, Bearman PS. 121.  2010. Social influence and the autism epidemic. Am. J. Sociol. 115:1387–434 [Google Scholar]
  122. Liu Y, Li X, Aryee MJ, Ekstrom TJ, Padyukov L. 122.  et al. 2014. GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. Am. J. Hum. Genet. 94:485–95 [Google Scholar]
  123. Lord C, Bishop SL. 123.  2015. Recent advances in autism research as reflected in DSM-5 criteria for autism spectrum disorder. Annu. Rev. Clin. Psychol. 11:53–70 [Google Scholar]
  124. Lundstrom S, Chang Z, Rastam M, Gillberg C, Larsson H. 124.  et al. 2012. Autism spectrum disorders and autistic like traits: similar etiology in the extreme end and the normal variation. Arch. Gen. Psychiatry 69:46–52 [Google Scholar]
  125. Lyall K, Baker A, Hertz-Picciotto I, Walker CK. 125.  2013. Infertility and its treatments in association with autism spectrum disorders: a review and results from the CHARGE study. Int. J. Environ. Res. Public Health 10:3715–34 [Google Scholar]
  126. Lyall K, Croen LA, Sjodin A, Yoshida CK, Zerbo O. 126.  et al. 2016. Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder and intellectual disability. Environ. Health Perspect. In press. https://doi.org/10.1289/EHP277 [Google Scholar]
  127. Lyall K, Munger KL, O'Reilly EJ, Santangelo SL, Ascherio A. 127.  2013. Maternal dietary fat intake in association with autism spectrum disorders. Am. J. Epidemiol. 178:209–20 [Google Scholar]
  128. Lyall K, Pauls DL, Spiegelman D, Ascherio A, Santangelo SL. 128.  2012. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses’ Health Study II. Autism Res. 5:21–30 [Google Scholar]
  129. Maglione MA, Das L, Raaen L, Smith A, Chari R. 129.  et al. 2014. Safety of vaccines used for routine immunization of U.S. children: a systematic review. Pediatrics 134:325–37 [Google Scholar]
  130. Martin LA, Ashwood P, Braunschweig D, Cabanlit M, Van de Water J, Amaral DG. 130.  2008. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav. Immun. 22:806–16 [Google Scholar]
  131. Matson JL, Cervantes PE. 131.  2014. Commonly studied comorbid psychopathologies among persons with autism spectrum disorder. Res. Dev. Disabil. 35:952–62 [Google Scholar]
  132. Mazina V, Gerdts J, Trinh S, Ankenman K, Ward T. 132.  et al. 2015. Epigenetics of autism-related impairment: copy number variation and maternal infection. J. Dev. Behav. Pediatr. 36:61–67 [Google Scholar]
  133. McDonald ME, Paul JF. 133.  2010. Timing of increased autistic disorder cumulative incidence. Environ. Sci. Technol. 44:2112–18 [Google Scholar]
  134. Miodovnik A, Engel SM, Zhu C, Ye X, Soorya LV. 134.  et al. 2011. Endocrine disruptors and childhood social impairment. Neurotoxicology 32:261–67 [Google Scholar]
  135. Moore GS, Kneitel AW, Walker CK, Gilbert WM, Xing G. 135.  2012. Autism risk in small- and large-for-gestational-age infants. Am. J. Obstet. Gynecol. 206:314e1–9 [Google Scholar]
  136. Mukherjee B, Ahn J, Gruber SB, Chatterjee N. 136.  2012. Testing gene-environment interaction in large-scale case-control association studies: possible choices and comparisons. Am. J. Epidemiol. 175:177–90 [Google Scholar]
  137. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK. 137.  et al. 2007. The epidemiology of autism spectrum disorders. Annu. Rev. Public Health 28:235–58 [Google Scholar]
  138. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N. 138.  et al. 2011. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 128:e488–95 [Google Scholar]
  139. Patel CJ, Ioannidis JP. 139.  2014. Studying the elusive environment in large scale. JAMA 311:2173–74 [Google Scholar]
  140. Philippat C, Bennett DH, Krakowiak P, Rose M, Hwang HM, Hertz-Picciotto I. 140.  2015. Phthalate concentrations in house dust in relation to autism spectrum disorder and developmental delay in the CHildhood Autism Risks from Genetics and the Environment (CHARGE) study. Environ. Health 14:56 [Google Scholar]
  141. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA. 141.  et al. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817–22 [Google Scholar]
  142. Pinto D, Delaby E, Merico D, Barbosa M, Merikangas A. 142.  et al. 2014. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94:677–94 [Google Scholar]
  143. Polo-Kantola P, Lampi KM, Hinkka-Yli-Salomaki S, Gissler M, Brown AS, Sourander A. 143.  2014. Obstetric risk factors and autism spectrum disorders in Finland. J. Pediatr. 164:358–65 [Google Scholar]
  144. Rai D, Lewis G, Lundberg M, Araya R, Svensson A. 144.  et al. 2012. Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J. Am. Acad. Child Adolesc. Psychiatry 51:467–76.e6 [Google Scholar]
  145. Raz R, Roberts AL, Lyall K, Hart JE, Just AC. 145.  et al. 2015. Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: a nested case-control analysis within the Nurses’ Health Study II cohort. Environ. Health Perspect. 123:264–70 [Google Scholar]
  146. Risch N, Hoffmann TJ, Anderson M, Croen LA, Grether JK, Windham GC. 146.  2014. Familial recurrence of autism spectrum disorder: evaluating genetic and environmental contributions. Am. J. Psychiatry 171:1206–13 [Google Scholar]
  147. Risi S, Lord C, Gotham K, Corsello C, Chrysler C. 147.  et al. 2006. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J. Am. Acad. Child Adolesc. Psychiatry 45:1094–103 [Google Scholar]
  148. Roberts A, Lyall K, Hart JE, Laden F, Just AC. 148.  et al. 2013. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. Environ. Health Perspect. 121:978–84 [Google Scholar]
  149. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. 149.  2007. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect. 115:1482–89 [Google Scholar]
  150. Robinson EB, Koenen KC, McCormick MC, Munir K, Hallett V. 150.  et al. 2011. Evidence that autistic traits show the same etiology in the general population and at the quantitative extremes (5%, 2.5%, and 1%). Arch. Gen. Psychiatry 68:1113–21 [Google Scholar]
  151. Rosen BN, Lee BK, Lee NL, Yang Y, Burstyn I. 151.  2015. Maternal smoking and autism spectrum disorder: a meta-analysis. J. Autism Dev. Disord. 45:1689–98 [Google Scholar]
  152. Rossignol DA, Frye RE. 152.  2012. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol. Psychiatry 17:290–314 [Google Scholar]
  153. Sacco R, Gabriele S, Persico AM. 153.  2015. Head circumference and brain size in autism spectrum disorder: a systematic review and meta-analysis. Psychiatry Res 234:239–51 [Google Scholar]
  154. Sandin S, Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. 154.  2012. Advancing maternal age is associated with increasing risk for autism: a review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry 51:477–86.e1 [Google Scholar]
  155. Sandin S, Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. 155.  2014. The familial risk of autism. JAMA 311:1770–77 [Google Scholar]
  156. Sandin S, Nygren KG, Iliadou A, Hultman CM, Reichenberg A. 156.  2013. Autism and mental retardation among offspring born after in vitro fertilization. JAMA 310:75–84 [Google Scholar]
  157. Sandin S, Schendel D, Magnusson P, Hultman C, Suren P. 157.  et al. 2016. Autism risk associated with parental age and with increasing difference in age between the parents. Mol. Psychiatry 21:5693–700 [Google Scholar]
  158. Schendel DE, Overgaard M, Christensen J, Hjort L, Jorgensen M. 158.  et al. 2016. Association of psychiatric and neurologic comorbidity with mortality among persons with autism spectrum disorder in a Danish population. JAMA Pediatr 170:243–50 [Google Scholar]
  159. Schieve LA, Clayton HB, Durkin MS, Wingate MS, Drews-Botsch C. 159.  2015. Comparison of perinatal risk factors associated with autism spectrum disorder (ASD), intellectual disability (ID), and co-occurring ASD and ID. J. Autism Dev. Disord. 45:2361–72 [Google Scholar]
  160. Schieve LA, Fountain C, Boulet SL, Yeargin-Allsopp M, Kissin DM. 160.  et al. 2015. Does autism diagnosis age or symptom severity differ among children according to whether assisted reproductive technology was used to achieve pregnancy?. J. Autism Dev. Disord. 45:2991–3003 [Google Scholar]
  161. Schmidt RJ, Hansen RL, Hartiala J, Allayee H, Schmidt LC. 161.  et al. 2011. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology 22:476–85 [Google Scholar]
  162. Schmidt RJ, Tancredi DJ, Krakowiak P, Hansen RL, Ozonoff S. 162.  2014. Maternal intake of supplemental iron and risk of autism spectrum disorder. Am. J. Epidemiol. 180:890–900 [Google Scholar]
  163. Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J. 163.  et al. 2012. Maternal periconceptional folic acid intake and risk of autism spectrum disorders and developmental delay in the CHARGE (CHildhood Autism Risks from Genetics and Environment) case-control study. Am. J. Clin. Nutr. 96:80–89 [Google Scholar]
  164. Schug TT, Blawas AM, Gray K, Heindel JJ, Lawler CP. 164.  2015. Elucidating the links between endocrine disruptors and neurodevelopment. Endocrinology 156:1941–51 [Google Scholar]
  165. Shattuck PT, Roux AM. 165.  2014. Autism: moving toward an innovation and investment mindset. JAMA Pediatr 168:698–99 [Google Scholar]
  166. Shelton JF, Geraghty EM, Tancredi DJ, Delwiche LD, Schmidt RJ. 166.  et al. 2014. Prenatal residential proximity to agricultural pesticides and neurodevelopmental disorders in the CHARGE study. Environ. Health Perspect. In press. https://doi.org/10.1289/ehp.1307044 [Google Scholar]
  167. Shelton JF, Tancredi DJ, Hertz-Picciotto I. 167.  2010. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res. 3:30–39 [Google Scholar]
  168. Shulha HP, Cheung I, Whittle C, Wang J, Virgil D. 168.  et al. 2012. Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch. Gen. Psychiatry 69:314–24 [Google Scholar]
  169. Singer HS, Morris C, Gause C, Pollard M, Zimmerman AW, Pletnikov M. 169.  2009. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J. Neuroimmunol. 211:39–48 [Google Scholar]
  170. Slappendel G, Mandy W, van der Ende J, Verhulst FC, van der Sijde A. 170.  et al. 2016. Utility of the 3Di short version for the diagnostic assessment of autism spectrum disorder and compatibility with DSM-5. J. Autism Dev. Disord. 46:1834–46 [Google Scholar]
  171. Smith IC, Reichow B, Volkmar FR. 171.  2015. The effects of DSM-5 criteria on number of individuals diagnosed with autism spectrum disorder: a systematic review. J. Autism Dev. Disord. 45:2541–52 [Google Scholar]
  172. Suades-Gonzalez E, Gascon M, Guxens M, Sunyer J. 172.  2015. Air pollution and neuropsychological development: a review of the latest evidence. Endocrinology 156:3473–82 [Google Scholar]
  173. Suren P, Roth C, Bresnahan M, Haugen M, Hornig M. 173.  et al. 2013. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309:570–77 [Google Scholar]
  174. Szatmari P, Chawarska K, Dawson G, Georgiades S, Landa R. 174.  et al. 2016. Prospective longitudinal studies of infant siblings of children with autism: lessons learned and future directions. J. Am. Acad. Child Adolesc. Psychiatry 55:179–87 [Google Scholar]
  175. Talbott EO, Arena VC, Rager JR, Clougherty JE, Michanowicz DR. 175.  et al. 2015. Fine particulate matter and the risk of autism spectrum disorder. Environ. Res. 140:414–20 [Google Scholar]
  176. Talbott EO, Marshall LP, Rager JR, Arena VC, Sharma RK, Stacy SL. 176.  2015. Air toxics and the risk of autism spectrum disorder: the results of a population based case-control study in southwestern Pennsylvania. Environ. Health 14:80 [Google Scholar]
  177. Tick B, Bolton P, Happe F, Rutter M, Rijsdijk F. 177.  2016. Heritability of autism spectrum disorders: a meta-analysis of twin studies. J. Child Psychol. Psychiatry 57:585–95 [Google Scholar]
  178. van Heijst BF, Geurts HM. 178.  2015. Quality of life in autism across the lifespan: a meta-analysis. Autism 19:158–67 [Google Scholar]
  179. Veiby G, Daltveit AK, Schjolberg S, Stoltenberg C, Oyen AS. 179.  et al. 2013. Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia 54:1462–72 [Google Scholar]
  180. Virk J, Liew Z, Olsen J, Nohr EA, Catov JM, Ritz B. 180.  2015. Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders. Autism 20:6710–18 [Google Scholar]
  181. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y. 181.  et al. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380–84 [Google Scholar]
  182. Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. 182.  2011. Residential proximity to freeways and autism in the CHARGE study. Environ. Health Perspect. 119:873–77 [Google Scholar]
  183. Volk HE, Kerin T, Lurmann F, Hertz-Picciotto I, McConnell R, Campbell DB. 183.  2014. Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology 25:44–47 [Google Scholar]
  184. Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. 184.  2013. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry 70:71–77 [Google Scholar]
  185. von Ehrenstein OS, Aralis H, Cockburn M, Ritz B. 185.  2014. In utero exposure to toxic air pollutants and risk of childhood autism. Epidemiology 25:851–58 [Google Scholar]
  186. Wagner GC, Reuhl KR, Cheh M, McRae P, Halladay AK. 186.  2006. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J. Autism Dev. Disord. 36:779–93 [Google Scholar]
  187. Walker CK, Krakowiak P, Baker A, Hansen RL, Ozonoff S, Hertz-Picciotto I. 187.  2015. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr 169:154–62 [Google Scholar]
  188. Wan Y, Hu Q, Li T, Jiang L, Du Y. 188.  et al. 2013. Prevalence of autism spectrum disorders among children in China: a systematic review. Shanghai Arch. Psychiatry 25:70–80 [Google Scholar]
  189. Weisskopf MG, Kioumourtzoglou MA, Roberts AL. 189.  2015. Air pollution and autism spectrum disorders: causal or confounded?. Curr. Environ. Health Rep. 2:430–39 [Google Scholar]
  190. Werling DM, Geschwind DH. 190.  2013. Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26:146–53 [Google Scholar]
  191. Whitehouse AJ, Holt BJ, Serralha M, Holt PG, Hart PH, Kusel MM. 191.  2013. Maternal vitamin D levels and the autism phenotype among offspring. J. Autism Dev. Disord. 43:71495–504 [Google Scholar]
  192. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT. 192.  et al. 2013. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155:997–1007 [Google Scholar]
  193. Windham GC, Zhang L, Gunier R, Croen LA, Grether JK. 193.  2006. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the San Francisco Bay Area. Environ. Health Perspect. 114:1438–44 [Google Scholar]
  194. Woodruff TJ, Zota AR, Schwartz JM. 194.  2011. Environmental chemicals in pregnant women in the United States: NHANES 2003–2004. Environ. Health Perspect. 119:878–85 [Google Scholar]
  195. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Blumberg SJ. 195.  2015. Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl. Health Stat. Rep. 87:1–20 [Google Scholar]
  196. Zaroff CM, Uhm SY. 196.  2012. Prevalence of autism spectrum disorders and influence of country of measurement and ethnicity. Soc. Psychiatry Psychiatr. Epidemiol. 47:395–98 [Google Scholar]
  197. Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA. 197.  2015. Maternal infection during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. 45:4015–25 [Google Scholar]
  198. Zerbo O, Traglia M, Yoshida C, Heuer LS, Ashwood P. 198.  et al. 2016. Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study. Transl. Psychiatry 6:e783 [Google Scholar]
  199. Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P. 199.  et al. 2014. Neonatal cytokines and chemokines and risk of autism spectrum disorder: the Early Markers for Autism (EMA) study: a case-control study. J. Neuroinflamm. 11:113 [Google Scholar]
  200. Zerbo O, Yoshida C, Gunderson EP, Dorward K, Croen LA. 200.  2015. Interpregnancy interval and risk of autism spectrum disorders. Pediatrics 136:651–57 [Google Scholar]
  201. Zwaigenbaum L, Bryson SE, Brian J, Smith IM, Roberts W. 201.  et al. 2016. Stability of diagnostic assessment for autism spectrum disorder between 18 and 36 months in a high-risk cohort. Autism Res 9:7790–800 [Google Scholar]
  202. Zwaigenbaum L, Szatmari P, Jones MB, Bryson SE, MacLean JE. 202.  et al. 2002. Pregnancy and birth complications in autism and liability to the broader autism phenotype. J. Am. Acad. Child Adolesc. Psychiatry 41:572–79 [Google Scholar]
  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error